David-Alexandre C. Gros
2020 - Tokai Pharmaceuticals
In 2020, David-Alexandre C. Gros earned a total compensation of $7.4M as Chief Executive Officer at Tokai Pharmaceuticals.
Compensation breakdown
| Option Awards | $7,176,879 |
|---|---|
| Salary | $150,000 |
| Other | $92,428 |
| Total | $7,419,307 |
Gros received $7.2M in option awards, accounting for 97% of the total pay in 2020.
Gros also received $150K in salary and $92.4K in other compensation.
Rankings
In 2020, David-Alexandre C. Gros' compensation ranked 1,286th out of 13,090 executives tracked by ExecPay. In other words, Gros earned more than 90.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,286 out of 13,090 | 90th |
Division Manufacturing | 458 out of 5,621 | 92nd |
Major group Chemicals And Allied Products | 159 out of 2,254 | 93rd |
Industry group Drugs | 137 out of 1,954 | 93rd |
Industry Pharmaceutical Preparations | 99 out of 1,459 | 93rd |
Source: SEC filing on April 28, 2022.